Swiss spatial biology firm Lunaphore raises 40 million Swiss francs

By The Science Advisory Board staff writers

March 24, 2023 -- Lausanne, Switzerland-based Lunaphore said Thursday it has closed 40 million Swiss francs (CHF) ($43.5 million) in a Series D1 financing.

The round was led by Ernst-Göhner Stiftung Beteiligungen (EGSB) and included current investors PHC Holdings, Swiss Entrepreneurs Fund, Occident, and Redalpine.

The financing also included a 10-million-euro venture debt facility provided by Norgine Ventures.

Lunaphore, whose goal is to enable spatial biology in the lab, said that it plans to use the funding to strengthen its growing portfolio in spatial biology as well as support commercial execution to address growing demand from customers.

"The funding comes in a meaningful time where we are experiencing excellent traction over the last 12 months since the first launch of our Comet product line," Ata Tuna Ciftlik, CEO of Lunaphore, said in a statement.

The Comet platform enables multiplex staining and image acquisition for the study of human tissue slides, using label-free antibodies that allow for high flexibility.

NanoString launches cloud-based, integrated informatics ecosystem for spatial biology
NanoString Technologies has launched its new AtoMx Spatial Informatics Portal, a cloud-based, integrated informatics ecosystem for spatial biology with...
Lunaphore spatial biology platform, Indica image analysis software characterize tumor microenvironment in new research
Lunaphore will present new research on June 21 at the Congress of the European Association for Cancer Research revealing how its Comet spatial biology...
Bruker offers highly multiplexed spatial proteomics, multiomic tissue imaging at large field-of-view
Bruker has announced large field-of-view highly multiplexed immunohistochemistry based on matrix-assisted laser desorption/ionization (MALDI HiPLEX-IHC)...
Ultivue enters several partnerships for AI-powered phenomics solutions
Ultivue has entered into multiple partnerships to expand on the use of artificial intelligence (AI) to provide high quality analysis of clinical trial...

Copyright © 2023

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter